BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7532289)

  • 1. Neurochemical effects of neuropeptide Y (NPY) and NPY2-36.
    Drumheller A; Bouali SM; Fournier A; St-Pierre S; Jolicoeur FB
    Neuropeptides; 1994 Nov; 27(5):291-6. PubMed ID: 7532289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neuropeptide Y (NPY) and [D-Trp32]NPY on monoamine and metabolite levels in dialysates from rat hypothalamus during feeding behavior.
    Matos FF; Guss V; Korpinen C
    Neuropeptides; 1996 Aug; 30(4):391-8. PubMed ID: 8914867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of 17 beta-estradiol and lithium on ovariectomized rat brain biogenic amines metabolism.
    Morissette M; Paolo TD
    J Psychiatr Res; 1996; 30(2):95-107. PubMed ID: 8816304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites.
    Drumheller AD; Gagné MA; St-Pierre S; Jolicoeur FB
    Neuropeptides; 1990 Mar; 15(3):169-78. PubMed ID: 1701223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
    Heidbreder C; Gewiss M; De Potter W; De Witte P
    Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ethanol and low-carbohydrate diet on contents of noradrenaline, dopamine, serotonin and their metabolites in rat brain].
    Hirose T
    Nihon Eiseigaku Zasshi; 1991 Aug; 46(3):755-61. PubMed ID: 1720179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.
    Heilig M; Vècséi L; Wahlestedt C; Alling C; Widerlöv E
    J Neural Transm Gen Sect; 1990; 79(3):193-208. PubMed ID: 2297403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
    Dunn AJ; Berridge CW
    Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neuropeptide Y on norepinephrine and serotonin metabolism in rat hypothalamus in vivo.
    Shimizu H; Bray GA
    Brain Res Bull; 1989 Jun; 22(6):945-50. PubMed ID: 2477116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine. Selective regional effects on central monoamines.
    Hadfield MG
    Mol Neurobiol; 1995; 11(1-3):47-53. PubMed ID: 8561967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute ethanol administration on monoamine and metabolite content in forebrain regions of ethanol-tolerant and -nontolerant alcohol-preferring (P) rats.
    Murphy JM; McBride WJ; Gatto GJ; Lumeng L; Li TK
    Pharmacol Biochem Behav; 1988 Jan; 29(1):169-74. PubMed ID: 2451255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
    Karoum F; Suddath RL; Wyatt RJ
    Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.
    Singer S; Rossi S; Verzosa S; Hashim A; Lonow R; Cooper T; Sershen H; Lajtha A
    Neurochem Res; 2004 Sep; 29(9):1779-92. PubMed ID: 15453274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NPY and NPY2-36 on body temperature and food intake following administration into hypothalamic nuclei.
    Bouali SM; Fournier A; St-Pierre S; Jolicoeur FB
    Brain Res Bull; 1995; 36(2):131-5. PubMed ID: 7895090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.
    Dellu-Hagedorn F; Fitoussi A; De Deurwaerdère P
    J Neurosci Methods; 2017 Mar; 280():54-63. PubMed ID: 28161298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-related changes in cerebral catecholamine and indoleamine metabolism: lack of effect of adrenalectomy and corticosterone.
    Dunn AJ
    J Neurochem; 1988 Aug; 51(2):406-12. PubMed ID: 2455773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.